Sculptra® is an enduring treatment approved by the FDA for restoration and/or correction of the signs of facial fat loss, or lipoatrophy, in people with human immunodeficiency virus. It is the first FDA-approved product of its kind for this condition.
Facial fat loss, or lipoatrophy, is the loss of fat beneath the skin, which can result in sunken cheeks, indentations, and hollow eyes. Sculptra® is a safe, synthetic, and biocompatible material injected below the surface of the skin in the area of fat loss. It provides a gradual and significant increase in skin thickness, improving the appearance of folds and sunken areas. No skin testing is required.
Sculptra® has been safely used outside the United States since 1999 in more than 150,000 patients under the trade names New-Fill™ and Sculptra®.
Sculptra® is an injectable product that restores and corrects the signs of facial fat loss by replacing lost volume. Sculptra® provides an increase in skin thickness, helping to create a more natural facial appearance in those with facial lipoatrophy.
Sculptra® is composed of poly-L-lactic acid, a synthetic material. Sculptra® is not made from human or animal sources and does not require a skin test. Poly-L-lactic acid (PLLA) is a biocompatible (does not harm the body), biodegradable (able to be broken down by the body) material that has been widely used for many years in surgical products. The effects are long-lasting; they were shown in a clinical study to last for up to 2 years after the first treatment session.
The effects of Sculptra® are enduring. In a clinical study, effects lasted for up to 2 years after the first treatment session in most patients. The results from Sculptra® are not immediate; Sculptra® provides a gradual increase in skin thickness. Dr. Gershenbaum will see you again in a few weeks to decide if additional injections are needed. Touch-up treatments may be needed to maintain the desired effects.
People with mild lipoatrophy will require fewer treatments than those with severe lipoatrophy.
When the word lipoatrophy is broken down, "lipo" means "fat," and "atrophy" means "the loss of." Facial lipoatrophy is the loss of fat beneath the skin, which can result in sunken cheeks, indentations, and hollow eyes.
Sculptra® is injected into the skin for restoration and/or correction of the signs of facial fat loss (lipoatrophy) in people with human immunodeficiency virus.
IMPORTANT SAFETY INFORMATION
Sculptra® should not be used by those who are allergic to any ingredient of Sculptra®. Sculptra® should not be injected by those who have an active skin infection or inflammation in the treatment area.
Side effects of Sculptra® may include the delayed appearance of small bumps under the skin in the treated area. Generally these bumps are not visible and may only be noticed when pressing on the treated area. Other side effects may include injection-related events at the site of injection, such as bleeding, tenderness or discomfort, redness, bruising or swelling.
*Indicates required fields
2954-B Aventura Blvd
Aventura, FL 33180
Ph: (305) 933-1838
Fax: (305) 933-1850